{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:10:13Z","timestamp":1765231813339,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008540","name":"Diana Helis Henry Medical Research Foundation","doi-asserted-by":"publisher","award":["26515","Le-2008","NS41264"],"award-info":[{"award-number":["26515","Le-2008","NS41264"]}],"id":[{"id":"10.13039\/100008540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.nbd.2009.09.024","type":"journal-article","created":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T07:33:53Z","timestamp":1255073633000},"page":"307-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration"],"prefix":"10.1016","volume":"37","author":[{"given":"Wen","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie K.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2009.09.024_bib1","first-page":"S47","article-title":"Iron dysregulation and Parkinson's disease","volume":"S6","author":"Andersen","year":"2004","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2009.09.024_bib2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1471-4159.2006.04258.x","article-title":"Therapeutic targets and potential of the novel brain-permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease","volume":"100","author":"Avramovich-Tirosh","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.09.024_bib3","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1523\/JNEUROSCI.2218-08.2008","article-title":"Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies","volume":"28","author":"Bedford","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.09.024_bib4","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/mds.21020","article-title":"Iron metabolism in Parkinsonian syndromes","volume":"21","author":"Berg","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2009.09.024_bib5","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1212\/WNL.0b013e3181a26b30","article-title":"Brain iron homeostasis and neurodegenerative disease","volume":"72","author":"Benarroch","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2009.09.024_bib6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.20937","article-title":"Proteasome inhibition and Parkinson's disease modeling","volume":"60","author":"Bove","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2009.09.024_bib46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neures.2008.10.009","article-title":"Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP (+)-elicited apoptosis","volume":"63","author":"Chen","year":"2004","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.nbd.2009.09.024_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/brain\/awl319","article-title":"Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation","volume":"130","author":"Chinnery","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2009.09.024_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jnr.490370405","article-title":"Isoforms of ferritin have a specific cellular distribution in the brain","volume":"37","author":"Connor","year":"1994","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2009.09.024_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ng571","article-title":"Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease","volume":"28","author":"Curtis","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2009.09.024_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson's disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2009.09.024_bib11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3181\/0712-RM-329","article-title":"Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo","volume":"233","author":"Du","year":"2008","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.nbd.2009.09.024_bib12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1471-4159.2002.01118.x","article-title":"Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease","volume":"83","author":"Faucheux","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.09.024_bib13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/11072","article-title":"Haem oxygenase-1 prevents cell death by regulating cellular iron","volume":"1","author":"Ferris","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2009.09.024_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1471-4159.2005.03341.x","article-title":"Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion","volume":"95","author":"Gal","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.09.024_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1196\/annals.1306.017","article-title":"The relevance of iron in the pathogenesis of Parkinson's disease","volume":"1012","author":"Gotz","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2009.09.024_bib16","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.21573","article-title":"What causes cell death in Parkinson's disease?","volume":"64","author":"Gupta","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2009.09.024_bib17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo, a novel therapy for Parkinson's disease","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2009.09.024_bib18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","article-title":"Cell death pathways in Parkinson's disease, proximal triggers, distal effectors, and final steps","volume":"14","author":"Levy","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.nbd.2009.09.024_bib19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/NEN.0b013e318186de64","article-title":"c-Jun N-terminal kinase mediates lactacystin-induced dopamine neuron degeneration","volume":"67","author":"Li","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2009.09.024_bib20","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.bbamcr.2008.05.008","article-title":"Ubiquitin-proteasome system mediates heme oxygenase-1 degradation through endoplasmic reticulum-associated degradation pathway","volume":"1783","author":"Lin","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2009.09.024_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1385\/JMN:24:3:401","article-title":"Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice, effect of neuroprotective drugs R-apomorphine and green tea polyphenol (\u2212)-epigallocatechin 3-gallate","volume":"24","author":"Mandel","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2009.09.024_bib22","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000286384.31050.b5","article-title":"Midbrain iron content in early Parkinson disease, a potential biomarker of disease status","volume":"70","author":"Martin","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2009.09.024_bib23","first-page":"125","article-title":"The effect of neuromelanin on the proteasome activity in human dopaminergic SH-SY5Y cells","volume":"S70","author":"Maruyama","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2009.09.024_bib24","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1471-4159.2005.03088.x","article-title":"Role of oxidative stress in paraquat-induced dopaminergic cell degeneration","volume":"93","author":"McCormack","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.09.024_bib25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neurobiolaging.2005.08.012","article-title":"Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease","volume":"27","author":"McNaught","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2009.09.024_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1020743405347","article-title":"Iron-activated iron uptake, a positive feedback loop mediated by iron regulatory protein 1","volume":"16","author":"Nunez","year":"2003","journal-title":"Biometals"},{"key":"10.1016\/j.nbd.2009.09.024_bib28","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1212\/01.wnl.0000262033.01945.9a","article-title":"Individual dopaminergic neurons show raised iron levels in Parkinson disease","volume":"68","author":"Oakley","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2009.09.024_bib29","doi-asserted-by":"crossref","first-page":"e925","DOI":"10.1371\/journal.pone.0000925","article-title":"Iron storage within dopamine neurovesicles revealed by chemical nano-imaging","volume":"2","author":"Ortega","year":"2007","journal-title":"PLoS ONE"},{"year":"2001","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","key":"10.1016\/j.nbd.2009.09.024_bib30"},{"key":"10.1016\/j.nbd.2009.09.024_bib31","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1523\/JNEUROSCI.1569-07.2007","article-title":"Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration","volume":"27","author":"Peng","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.09.024_bib32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2008.07.001","article-title":"Genetics of iron regulation and the possible role of iron in Parkinson's disease","volume":"32","author":"Rhodes","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2009.09.024_bib33","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.0804373105","article-title":"Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease","volume":"105","author":"Salazar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.09.024_bib34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/mds.22314","article-title":"Complicated recessive dystonia parkinsonism syndromes","volume":"24","author":"Schneider","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2009.09.024_bib35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00216-005-3423-x","article-title":"Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats","volume":"383","author":"Tarohda","year":"2005","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.nbd.2009.09.024_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.wco.0000137534.61244.d1","article-title":"Neurodegenerative disease and iron storage in the brain","volume":"17","author":"Thomas","year":"2004","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2009.09.024_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mds.10650","article-title":"Clinical heterogeneity of neurodegeneration with iron accumulation-1 (Hallervorden-Spatz Syndrome) and pantothenate kinase associated neurodegeneration (PKAN)","volume":"19","author":"Thomas","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2009.09.024_bib38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jnr.10463","article-title":"Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress","volume":"71","author":"Thompson","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2009.09.024_bib39","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ymthe.2006.06.009","article-title":"Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease","volume":"14","author":"Vercammen","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2009.09.024_bib40","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1128\/MCB.01111-06","article-title":"Iron-dependent degradation of apo-IRP1 by the ubiquitin-proteasome pathway","volume":"27","author":"Wang","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2009.09.024_bib41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0197-4580(93)90112-O","article-title":"New stereological methods for counting neurons","volume":"14","author":"West","year":"1993","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2009.09.024_bib42","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1046\/j.1471-4159.2001.00186.x","article-title":"Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes","volume":"76","author":"Zecca","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.09.024_bib43","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.bbrc.2005.05.150","article-title":"Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration","volume":"333","author":"Zhang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2009.09.024_bib44","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.neurobiolaging.2007.11.025","article-title":"Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells","volume":"30","author":"Zhang","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2009.09.024_bib45","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1096\/fj.07-8386com","article-title":"Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators","volume":"21","author":"Zhu","year":"2007","journal-title":"FASEB J."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109002769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109002769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:07:22Z","timestamp":1760850442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996109002769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0969996109002769"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2009.09.024","relation":{},"ISSN":["0969-9961"],"issn-type":[{"type":"print","value":"0969-9961"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2009.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}